Making an unwavering commitment to support people with serious medical conditions

Our Products

Our track record of discovery, development and commercialization of important therapies includes Latuda® (lurasidone HCl), and Aptiom®.

Sunovion Canada has a robust portfolio and is expanding leadership in treatments in the areas of central nervous system and infectious disease.